Advice statement to the Office of Pharmaceuticals Management Strategies on the national strategy for high-cost drugs for rare diseases online engagement

Publication date: 01-06-2021

Version: Current

Language available: Bilingual

Download publication

The Canadian Institute of Actuaries (CIA) welcomes this opportunity to offer its inputs on the National Strategy for High-Cost Drugs for Rare Diseases.

The CIA recently released a public statement on the issue of national pharmacare. Although the statement has a wider focus than this consultation, there are elements of our proposal that address the need for access to high-cost drugs and how this should be managed as part of a strategy for drug insurance coverage for all Canadians. 


Categories: Statements

Types: Advice statements

Pages: 8

Format: PDF

Accession no.: 221054